Standout Papers

Immediate Impact

5 from Science/Nature 56 standout
Sub-graph 1 of 20

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
2 intermediate papers

Works of Paul Brunetta being referenced

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
2012 Standout
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
2009 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Paul Brunetta 2478 567 662 1664 1176 30 3.5k
Kevin Latinis 2069 274 438 1870 1257 21 3.9k
Cheryl Yarboro 3192 242 721 2521 828 51 5.2k
Barri J. Fessler 3576 390 397 2261 667 63 5.3k
W. Joseph McCune 3494 688 256 3055 866 97 6.0k
Romeo Maciuca 1529 263 342 1244 737 25 2.4k
Holly M. Bastian 3221 142 370 2035 661 41 3.9k
Graham Hughes 2748 250 407 1590 603 48 3.7k
Jorge Sánchez‐Guerrero 5218 351 711 2933 1684 86 6.8k
Howard A. Austin 3297 740 2231 1256 515 41 6.0k
Z. John Zhong 4293 134 351 3375 2497 22 5.1k

All Works

Loading papers...

Rankless by CCL
2026